Skip to content
drillr.ai
Sign up

301108.SZ

Tongling Jieya Biologic Technology Co., Ltd.

SZSE · C 制造业 · CN

CNY 46.97
−0.45%
Ask drillr

  • Sep 24, 2026, 08:32 UTC

    Mingyuan Fund and its concert party Zhongyi Mingyuan reduced their combined stake in Jieya Co. by 1.1648% to 10.7301% through block and centralized bidding trades on September 18-23, 2026.

    Source:

  • Aug 28, 2026, 09:55 UTC

    Jieya Co., Ltd. planned to accrue an impairment loss of 9.6275 million yuan for the first half of 2026.

    Source:

  • Aug 28, 2026, 09:55 UTC

    Jieya Co., Ltd. announced its first-half 2026 results: revenue of 419 million yuan, up 35.07% year-on-year; net profit attributable to shareholders of 41.6636 million yuan, up 27.87% year-on-year; non-GAAP net profit of 18.1604 million yuan, down 31.87% year-on-year.

    Source:

  • Aug 28, 2026, 09:55 UTC

    Jieya Co., Ltd. proposed a cash dividend of 1.2 yuan per 10 shares (tax inclusive) based on a base of 113 million shares, with no bonus shares and no capital reserve conversion.

    Source:

  • Aug 18, 2026, 12:10 UTC

    Jieya Co., Ltd. announced that its shareholders holding more than 5% of shares, Tongling Mingyuan Circular Economy Industrial Venture Capital Fund Center (Limited Partnership) and its concert party Suzhou Industrial Park Zhongyi Mingyuan Venture Capital Center (Limited Partnership), plan to reduce their combined holdings by up to 4.99% of the company's total shares between September 10, 2026 and December 9, 2026.

    Source: